[{"address1": "221 Crescent Street", "address2": "Building 17 Suite 102b", "city": "Waltham", "state": "MA", "zip": "02453", "country": "United States", "phone": "650 394 5230", "website": "https://www.apogeetherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 91, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael Thomas Henderson M.D.", "age": 34, "title": "CEO & Director", "yearBorn": 1990, "fiscalYear": 2023, "totalPay": 1171208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jane Pritchett V. Henderson", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 843643, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl Linden Dambkowski M.D.", "age": 39, "title": "Chief Medical Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 870833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Noel  Kurdi", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Batters J.D.", "age": 48, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Emily  Cox", "title": "VP & Head of People", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rebecca  Dabora Ph.D.", "age": 64, "title": "Chief Development Officer", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Wendy  Aspden-Curran", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Drew  Badger Ph.D.", "title": "Senior VP and Head of Regulatory Affairs & Toxicology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Monica  Forbes", "age": 48, "title": "Senior Vice President of Finance", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 30.53, "open": 30.25, "dayLow": 29.6362, "dayHigh": 31.469, "regularMarketPreviousClose": 30.53, "regularMarketOpen": 30.25, "regularMarketDayLow": 29.6362, "regularMarketDayHigh": 31.469, "payoutRatio": 0.0, "forwardPE": -8.2736845, "volume": 683160, "regularMarketVolume": 683160, "averageVolume": 550628, "averageVolume10days": 615400, "averageDailyVolume10Day": 615400, "bid": 31.08, "ask": 31.51, "bidSize": 12, "askSize": 7, "marketCap": 1789027200, "fiftyTwoWeekLow": 29.636, "fiftyTwoWeekHigh": 72.29, "fiftyDayAverage": 40.7178, "twoHundredDayAverage": 46.626274, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1275118464, "profitMargins": 0.0, "floatShares": 37879129, "sharesOutstanding": 43416300, "sharesShort": 8321096, "sharesShortPriorMonth": 8502020, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.1462, "heldPercentInsiders": 0.116409995, "heldPercentInstitutions": 1.3269501, "shortRatio": 16.11, "shortPercentOfFloat": 0.2152, "impliedSharesOutstanding": 56902900, "bookValue": 12.907, "priceToBook": 2.4358876, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -146663008, "trailingEps": -2.43, "forwardEps": -3.8, "52WeekChange": -0.24676567, "SandP52WeekChange": 0.16050637, "quoteType": "EQUITY", "currentPrice": 31.44, "targetHighPrice": 110.0, "targetLowPrice": 80.0, "targetMeanPrice": 92.28571, "targetMedianPrice": 90.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 526048992, "totalCashPerShare": 9.245, "totalDebt": 12140000, "quickRatio": 16.277, "currentRatio": 16.39, "debtToEquity": 1.653, "returnOnAssets": -0.18515, "returnOnEquity": -0.25648, "freeCashflow": -86914000, "operatingCashflow": -133214000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "APGE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1689341400000, "postMarketChangePercent": 1.71755, "postMarketPrice": 31.98, "postMarketChange": 0.539999, "regularMarketChange": 0.90999985, "regularMarketDayRange": "29.6362 - 31.469", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 550628, "fiftyTwoWeekLowChange": 1.8040009, "fiftyTwoWeekLowChangePercent": 0.060871944, "fiftyTwoWeekRange": "29.636 - 72.29", "fiftyTwoWeekHighChange": -40.85, "fiftyTwoWeekHighChangePercent": -0.56508505, "fiftyTwoWeekChangePercent": -24.676567, "earningsTimestampStart": 1741008600, "earningsTimestampEnd": 1741354200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.43, "epsForward": -3.8, "epsCurrentYear": -3.094, "priceEpsCurrentYear": -10.161603, "fiftyDayAverageChange": -9.2778, "fiftyDayAverageChangePercent": -0.22785611, "twoHundredDayAverageChange": -15.186274, "twoHundredDayAverageChangePercent": -0.32570207, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-07-14", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1740790753, "regularMarketTime": 1740776401, "exchange": "NGM", "messageBoardId": "finmb_1816591253", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.9806743, "regularMarketPrice": 31.44, "shortName": "Apogee Therapeutics, Inc.", "longName": "Apogee Therapeutics, Inc.", "displayName": "Apogee Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]